Recent Headlines
Within Biotechnology
University of Malaga Researchers Collaborate with AST to Develop New Lignin-Based Products
AST to send multiple shipments of its Organosolv lignin for continued product development efforts. - December 07, 2016 - American Science and Technology
Life Science Leader and ClinicalLeader.com Announce New Forum for Small to Mid-Sized Pharma and Biotech Companies
Life Science Leader and ClinicalLeader.com are excited to introduce Clinical Leader Forum, a new conference tailored just for executives at pharma and biotech sponsor companies that rely on contract research organizations for clinical trials. The inaugural event is scheduled for May 10 through 11... - December 07, 2016 - Clinical Leader Forum
New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs
New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC
Research to be Presented at ASH Annual Meeting Shows Verseon’s New Class of Anticoagulants Prevents Thrombosis While Preserving Platelet Function
Verseon’s anti coagulants are as effective as NOACS at preventing arterial and venous thromboembolism and thrombin-induced pulmonary embolism. Lead candidate has low renal clearance compared to NOACS - highly desirable for patients with impaired renal function. - November 30, 2016 - Verseon
Global Cancer Technology, Inc. Signs Licensing Agreement with the University of California San Diego
Announcing an agreement to purchase patent and IP technology from UCSD for a novel way to track medical instruments using Nano Quantum Dots - November 25, 2016 - Global Cancer Technology, Inc
Zifo RnD Solutions Ranked Number 40 Fastest Growing Technology Company on the Deloitte Technology Fast 50™ India 2016
Attributes its 146% revenue growth to the Zifo team’s collective strength and commitment towards customer’s success. - November 23, 2016 - Zifo
Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults
A new transdermal gel has been developed and is now available by prescription only to treat the symptoms of gout attacks. ColciGel® is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems. - November 22, 2016 - Gensco Pharma
Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds
Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications. - November 19, 2016 - Gensco Pharma
Mount Sinai Beth Israel Receive Award from the Department of Defense to Study Gulf War Illness with electroCore’s Non-Invasive Vagus Nerve Stimulation Therapy
The Pain & Fatigue Study Center at Mount Sinai Beth Israel in New York has been awarded a United States Army Medical Research grant to conduct a study into the treatment of veterans of the 1990-1991 Gulf War who have Gulf War Illness using electroCore’s non-invasive vagus nerve... - November 17, 2016 - electroCore
New Gastrointestinal Pathogen Assays Available from ALPCO
ALPCO is now offering a line of research assays for the investigation of common bacterial and parasitic gastrointestinal (GI) pathogens including Giardia lamblia, Cryptosporidium spp., Blastocystis hominis, Entamoeba histolytica/dispar, and Clostridium difficile. These assays can be used to... - November 15, 2016 - ALPCO
Virun® Launches a Line of Shelf-Stable Probiotic Multi-Serving Powders and Emulsions
Virun® NutraBiosciences® Technology Revolutionizes Probiotics with Non-refrigerated Probiotic Single-serving Powders and Emulsions Available to Manufacturers. - November 15, 2016 - VIRUN
New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1
ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016 - ALPCO
NuvOx Pharma Awarded NIH Grant to Develop Technology to Increase Sensitivity and Specificity of Breast Cancer Diagnosis
NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, “B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer.” Evan Unger, MD, co-founder of NuvOx, a co-principal investigator of the... - November 03, 2016 - NuvOx Therapeutics
Viral Vectors and Plasmid DNA Manufacturing to Witness 16% Annual Growth, Predicts Roots Analysis
Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapidly growing market of gene therapy vectors. Kashish Goel, the principal analyst, said, “Gene... - November 02, 2016 - Roots Analysis
Thrivous Launches Serenity, the Nightly Nootropic
Thrivous, a human intelligence and vitality company, has developed and brought to market Serenity, the nightly nootropic. Serenity is designed for nightly use to promote calm and sleep, and to improve next-day focus. It is also designed to complement Clarity, the first nootropic brought to market... - October 28, 2016 - Thrivous
Thrivous Announces Science Advisor Board
Thrivous, a human intelligence and vitality company, announces the formation of its science advisor board. The board will inform ongoing product and service development. Formation of the board reflects Thrivous' commitment to guidance from consensus science in its mission to help customers access... - October 28, 2016 - Thrivous
New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories
5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction. - October 24, 2016 - Life Science Strategy Group, LLC
Presentation from electroCore Shows That Healthcare Costs for Patients with a Primary Headache Diagnosis Cost Four Times More Than a Healthy Patient Due to Comorbidities
Research presented at the Academy of Managed Care Pharmacy (AMCP) Nexus in early October in Washington, DC, showed that 60 percent of adult patients who were diagnosed with primary headache had one or more comorbidities which raised the average annual cost of their healthcare to over $20,000. This... - October 22, 2016 - electroCore
Experimentica Ltd. Appoints New Director of In Vivo Pharmacology
Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately. Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental... - October 22, 2016 - Experimentica Ltd
Nerviano Medical Sciences Presents Data Regarding a Potent New Cytotoxic Molecule for ADC Generation
NMS-P945 is a potent, innovative and proprietary cytotoxic molecule in the nms pipeline, hbighly suited to conjugation with targeted antibodies. - October 20, 2016 - NMS Group
Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing
Dr. Leslie Miller backs the creation of a Registry of Cell Therapy to provide guidelines for stem cell use in therapies and treatments. - October 17, 2016 - Bioscience Americas
HyperFlux™ PRO Plus Now Available in Europe
Full Raman spectroscopy system joins Tornado Spectral Systems' stand-alone spectrometers. - October 14, 2016 - Tornado Spectral Systems
Oxford AHSN Recognizes the SGC with Its Annual Public-Private Collaboration Award
Pioneering work to accelerate drug discovery earned the SGC the 2016 Oxford Academic Health Science Network (Oxford AHSN) collaboration award. - October 11, 2016 - The SGC
Bioscience Americas Sponsors "Solutions for a Healthier World Foundation"
Independent not-for-profit will provide stem cell therapies for the less fortunate. - October 06, 2016 - Bioscience Americas
Stroke Patients Able to Walk Again After Stem Cell Therapy by Dr. Henderson at Regenerative Medical Group
Dr. Bryn J. Henderson and his Regenerative Medical Group can help stroke patients return to normal life as much as possible through advanced stem cell therapy. The touching story of Bill Dendiu, stroke survivor, who was able to walk again after innovative procedures at RMG gives hope to many patients. - October 06, 2016 - Regenerative Medical Group
Smart Wearables: The Future of Personalized Healthcare
Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape with respect to key players and specific applications of the diverse range of... - October 03, 2016 - Roots Analysis
Children with High Grade Brain Tumors Will Soon be Able to Receive Cutting Edge Oncolytic Virus Therapy
Re-engineered Polio Virus with Dramatic Response in Adults to be Made Available to Children in a Phase 1 Clinical Trial Jointly Funded by The Andrew McDonough B+ Foundation and Solving Kids’ Cancer. - September 30, 2016 - Solving Kids' Cancer
American Science and Technology Awarded Second New Patent
New Patented Process Can Produce High Quality Pulp as Well as Desirable Bio-Renewable Materials - September 29, 2016 - American Science and Technology
Spherium Biomed Starts Efficacy Trial Cyclatop for the Treatment of Atopic Dermatitis in Adults and Infants
The clinical trial is a pilot study (the Cyclatop study) for the evaluation of SP14019-F-01 topical solution for the treatment of atopic dermatitis. It is designed to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019-F-01 across all group ages for the treatment of mild... - September 29, 2016 - Spherium Biomed
STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products
Virun® Nutra-BioSciences® Creates New Series of Video Broadcasts Called STATIC, Focusing on Nutrition Found in Finished Products. - September 27, 2016 - VIRUN
Spaulding Clinical Research Named “Best Phase I Drug Development CRO”
International Life Sciences continue to have a global impact and be captivated by daily breakthroughs that focus on companies, departments, and individuals who truly deserve to be identified as unique in their industry. As such, Spaulding Clinical Research keeps conducting tests and research, embracing the most advanced technology to forge ahead into clinical research and biometric solutions. - September 24, 2016 - Spaulding Clinical Research, LLC
Quorum Innovations Announces Availability of Human Microbiome Therapeutics to Treat Common Skin Conditions and Metabolic Disorders
Probiomic Therapeutics™ for Eczema, Atopic Dermatitis, Eosinophilic Esophagitis (EoE), Metabolic Disorders - September 24, 2016 - Quorum Innovations
AUM LifeTech's Self-Delivering FANA Antisense Oligonucleotides to be Distributed by MoBiTec Germany
AUMsilence self-delivering oligos achieve highly efficient and potent antisense-based gene knockdown. No need to use toxic transfection reagents. Especially designed for primary cells and very difficult-to-transfect cell types. - September 24, 2016 - MoBiTec GmbH
For Lentivirus Production: TransIT®-Lenti Transfection Reagent, Available from MoBiTec, Germany
TransIT®-Lenti Transfection Reagent, manufactured by Mirus Bio, US, is designed to enhance delivery of packaging and transfer vectors to adherent HEK 293T cell types and increase recombinant lentivirus production. - September 23, 2016 - MoBiTec GmbH
MR Solutions to Supply Cryogen-Free 7T Simultaneous PET-MR Preclinical Imaging System for the Study of Alzheimer’s and Stroke at the University of Southern California
MR Solutions has received an order for a high-powered 7T, cryogen-free, preclinical PET-MRI multi-modality imaging system from the newly formed pre-clinical imaging resource at the Zilkha Neurogenetic Institute (ZNI) at the Keck School of Medicine of the University of Southern California... - September 22, 2016 - MR Solutions
Batavia Biosciences Receives Grant to Develop New Vaccine Against Rotavirus
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. This vaccine aims to save many young children’s lives worldwide. - September 21, 2016 - Batavia Biosciences
ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader
ALPCO has launched its new STELLUX® Chemiluminescent Plate Reader, an economical and versatile system for any size lab. - September 20, 2016 - ALPCO
Bioscience Americas Announces New Cellular Immunotherapy Treatment
The treatment represents a breakthrough therapy that incorporates advanced stem cell protocols. - September 20, 2016 - Bioscience Americas
HDAC Inhibitors: Controlling Disease Propagation by Regulating Gene Expression
Roots Analysis has announced the addition of the “HDAC Inhibitors Market, 2016-2026” report to their list of offerings. It provides a comprehensive study on the current landscape of the evolving pipeline in this area. With five commercialized products, the market has gained the... - September 19, 2016 - Roots Analysis
SE3D Awarded Phase Two NSF Grant
SE3D, a company leading innovation in bioscience education and technology, announced today that it has been awarded the Small Business and Innovation Research (SBIR) Phase II grant from the National Science Foundation (NSF). The NSF SBIR grant is awarded to organizations who create innovative... - September 16, 2016 - SE3D
We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth
Go under the sea in a yellow submarine and cast your vote for the next Omega-3 Smoothie - September 15, 2016 - VIRUN
Recursion Pharmaceuticals Receives Fast-Track SBIR Grant to Study Age-Related Disease
Recursion Pharmaceuticals, an exciting biotech company located in the University of Utah’s Research Park, today announced a $223,000 Phase I Small Business Innovation Research award from the National Institutes of Health (NIH) via the National Institute on Aging (NIA). The award, which has... - September 15, 2016 - Recursion Pharmaceuticals
The Journal Headache Reports That electroCore’s Non-Invasive Vagus Nerve Stimulator is an Effective Bioelectric Medicine for Episodic Cluster Headache
In a multi-centered, sham-controlled study conducted in the United States, episodic cluster headache patients using the gammaCore non-invasive vagus nerve stimulation device (nVNS) had a significant and clinically meaningful benefit within 15 minutes of the treatment of the attack, as compared with... - September 14, 2016 - electroCore
CHI's 8th Annual SCOPE: Summit for Clinical Ops Executives Returns to Miami, January 24-26, 2017
1,200+ Executives to gather for solutions on various aspects of clinical trial planning and management at 13 co-located conferences and 2 symposia - September 13, 2016 - Cambridge Healthtech Institute
The SGC Releases Enabling Information to Accelerate Drug Discovery
Data packages provide a crucial link between human genetics and disease biology to accelerate drug discovery in cancer and malaria. - September 13, 2016 - The SGC
Novel Drugs and Devices to Lower Intraocular Pressure: Revolutionary Advances Poised to Grow at a Rapid Rate
Roots Analysis has announced the addition of the “Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026” report to its list of offerings. The report provides a detailed study on the current market landscape, future trends and applications of these novel treatment options. - September 12, 2016 - Roots Analysis
CRISPR/Cas9 - Request a Free Sample for Your Genome Editing Research
The use of CRISPR/Cas9 has emerged as a powerful method for genome editing that can be delivered in multiple formats. MoBiTec together with Mirus Bio provide solutions to address delivery of Cas9 and guide RNA in plasmid, RNA, or RNP format. - September 10, 2016 - MoBiTec GmbH
MR Solutions Accelerates Sales of Its Preclinical Multi-Modality, High Field, Cryogen Free Scanners
Simultaneous and sequential PET-MR imaging systems with proven reference sites on show at 2016 WMIC in New York. - September 08, 2016 - MR Solutions
Tornado Spectral Systems to Present and Exhibit at SciX 2016
Leading manufacturer of optical spectrometers and Raman spectroscopy systems to highlight innovative technologies at annual SciX conference. - September 08, 2016 - Tornado Spectral Systems
Dextra UK Launched the World's Largest Commercial Glycan Array, Marketed in Germany and Other Countries Through Its Authorized Distributor MoBiTec GmbH
Dextra's Glycan Array Kit is a valuable tool for use in determining the glycan binding profile of proteins, eukaryotic cells, viruses, spores, bacteria, and parasites. It features 104 unique glycans carefully selected from cutting-edge libraries. - September 02, 2016 - MoBiTec GmbH